NEW YORK (GenomeWeb) – Researchers have teased out a gene expression program that is associated with resistance to immunotherapy in melanoma. Inhibiting this program could improve treatment response.
While immunotherapies like immune checkpoint inhibitors have led to sometimes-dramatic responses in a portion of cancer patients, others don't respond to the treatment.